Igc Pharma, Inc. (IGC) SEC Filings — 2024
15 SEC filings for Igc Pharma, Inc. (IGC) in 2024.
Filings
- IGC Pharma Files 10-Q for Q3 2024 — 10-Q · Nov 12, 2024
- IGC Pharma Files 8-K: Material Agreement, Equity Sales — 8-K · Sep 27, 2024
- IGC Pharma Files 8-K on Security Holder Votes — 8-K · Aug 27, 2024
- Bradbury Fund Amends IGC Pharma Stake Filing — SC 13D/A · Aug 14, 2024
- IGC Pharma Files Q2 2024 Report — 10-Q · Aug 7, 2024
- IGC Pharma Enters Loan Agreement, Files 8-K — 8-K · Aug 2, 2024
- IGC Pharma Files Definitive Additional Materials — DEFA14A · Jul 9, 2024
- IGC Pharma Files 2024 Proxy Statement — DEF 14A · Jul 8, 2024
- IGC Pharma Files 2024 Annual Report — 10-K · Jun 24, 2024
- Bradbury Fund Takes 5% Stake in IGC Pharma — SC 13D · May 21, 2024
- IGC Pharma Files 8-K with Regulatory Updates — 8-K · Apr 5, 2024
- IGC Pharma Files 8-K: Material Agreement, Equity Sales — 8-K · Mar 28, 2024
- IGC Pharma Enters Material Definitive Agreement — 8-K · Mar 22, 2024
- IGC Pharma Appoints New Officers, Clinical Trial Updates — 8-K · Mar 13, 2024
- IGC Pharma, Inc. Files Quarterly Report on Form 10-Q for Period Ended December 31, 2023 — 10-Q · Feb 14, 2024